Correlation Between Fate Therapeutics and Revelation Biosciences
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Revelation Biosciences, you can compare the effects of market volatilities on Fate Therapeutics and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Revelation Biosciences.
Diversification Opportunities for Fate Therapeutics and Revelation Biosciences
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Fate and Revelation is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Revelation Biosciences go up and down completely randomly.
Pair Corralation between Fate Therapeutics and Revelation Biosciences
Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the Revelation Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Fate Therapeutics is 1.55 times less risky than Revelation Biosciences. The stock trades about -0.17 of its potential returns per unit of risk. The Revelation Biosciences is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest 1.23 in Revelation Biosciences on September 24, 2024 and sell it today you would lose (0.37) from holding Revelation Biosciences or give up 30.08% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 90.0% |
Values | Daily Returns |
Fate Therapeutics vs. Revelation Biosciences
Performance |
Timeline |
Fate Therapeutics |
Revelation Biosciences |
Fate Therapeutics and Revelation Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fate Therapeutics and Revelation Biosciences
The main advantage of trading using opposite Fate Therapeutics and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Revelation Biosciences vs. Fate Therapeutics | Revelation Biosciences vs. Sana Biotechnology | Revelation Biosciences vs. Caribou Biosciences | Revelation Biosciences vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |